Detection of Human GPCR Activity in Drosophila S2 Cells Using the Tango System

Emil Salim1,2, Aki Hori1, Kohei Matsubara3

  • 1Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Osaka 920-1192, Japan.

Insights

This study validates the Tango assay in Drosophila S2 cells for detecting G protein-coupled receptor (GPCR) activation. The system accurately measures human Dopamine Receptor D4 (DRD4) activity and specificity, enabling efficient ligand screening.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • G protein-coupled receptors (GPCRs) are crucial cell surface proteins mediating signal transduction.
  • Understanding GPCR activation is vital for numerous physiological processes and drug discovery.

Purpose of the Study:

  • To validate the Tango assay for detecting GPCR activation in Drosophila Schneider 2 (S2) cells.
  • To assess the specificity and utility of this system for studying human Dopamine Receptor D4 (DRD4).

Main Methods:

  • Co-transfection of LexA-tagged human DRD4 and a luciferase reporter in Drosophila S2 cells.
  • Stimulation with dopamine and measurement of luciferase activity to quantify receptor activation.
  • Testing specificity using octopamine and a novel activating compound.

Main Results:

  • The Tango assay in Drosophila S2 cells successfully detected human DRD4 activation by dopamine.
  • The system demonstrated high specificity, showing no response to octopamine.
  • Activation by a novel compound was also effectively detected, confirming assay sensitivity.

Conclusions:

  • Drosophila S2 cells combined with the Tango assay offer a viable model for studying human GPCR function.
  • This cost-effective system facilitates rapid screening of GPCR ligands and assessment of ligand specificity.
  • The validated system supports research into GPCRs and the development of targeted therapeutics.

Related Concept Videos